Director, Search & Evaluation

Facility:
Business Development & Strategy

Cambridge, MA, US

The Novo Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas.

Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve

Global Business Development (GBD) contributes to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists–looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit and to help patients in all of our current therapy areas.

Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve. Search, Evaluation & Intelligence (SE&I) is part of GBD and acts as the primary entry point for external drug and technology opportunities relevant to Novo.

The search for novel therapeutics focuses on diabetes, obesity, liver and CVD, blood & endocrine disorders as well as Consumer Rx. Besides our therapeutic areas of interest, SE&I supports the identification of cutting-edge enabling technologies across several modalities. Working cross-functionally, SE&I supports the assessment of such external opportunities all the way through due diligence and contractual negotiation, and this role is directly responsible for cross-functionally leading evaluations of BD opportunities from initial evaluation through due diligence.

The position is part of the global SE&I evaluation team with members located predominantly in Denmark and Cambridge, MA, US. Reports to the Head of Global Evaluation. The role will interact cross-functionally with stakeholders from the entire value chain while working in close collaboration with Novo’s Business Development teams located in Denmark and Cambridge. This position will also leverage their networks and actively engage with external stakeholders including biotech companies, venture capital firms and large-cap pharma communities.

The role has no direct or indirect reports.

• Identify novel pipeline assets and enabling technologies
• Lead in-depth evaluation and due diligence process
• Provide support to Business Development during negotiation of licenses and collaborations in alignment with SE&I
• Work cross-organizationally with stakeholders from R&D to Commercial and beyond to ensure alignment
• Build and maintain BD opportunity landscapes
• Continuously provide input to BD priorities and Therapy area strategies
• Establish Novo as the preferred partner within relevant therapy areas
• Actively engage with external stakeholders particularly venture capital, biotech companies and other large-cap pharma
• Participate in partnering events, scientific conferences and other relevant networking events

10-20% overnight travel required;
May require international travel.

• Master’s degree in business or life science is required; MD or PhD degree…